Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 5
2015 1
2016 9
2017 2
2019 8
2020 7
2021 9
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
A patent review of EZH2 inhibitors from 2017 and beyond.
Wan G, Feng H, Su C, Zhu Y, Zhang L, Zhang Q, Yu L. Wan G, et al. Among authors: zhu y. Expert Opin Ther Pat. 2023 Apr;33(4):293-308. doi: 10.1080/13543776.2023.2206018. Epub 2023 May 8. Expert Opin Ther Pat. 2023. PMID: 37095742 Review.
Methylation of dual-specificity phosphatase 4 controls cell differentiation.
Su H, Jiang M, Senevirathne C, Aluri S, Zhang T, Guo H, Xavier-Ferrucio J, Jin S, Tran NT, Liu SM, Sun CW, Zhu Y, Zhao Q, Chen Y, Cable L, Shen Y, Liu J, Qu CK, Han X, Klug CA, Bhatia R, Chen Y, Nimer SD, Zheng YG, Iancu-Rubin C, Jin J, Deng H, Krause DS, Xiang J, Verma A, Luo M, Zhao X. Su H, et al. Among authors: zhu y. Cell Rep. 2021 Jul 27;36(4):109421. doi: 10.1016/j.celrep.2021.109421. Cell Rep. 2021. PMID: 34320342 Free PMC article.
Editorial: Epigenetic regulation and therapy resistance in cancer.
Zhu Y, Pittella-Silva F, Wang Y, Wang T, Long F. Zhu Y, et al. Front Pharmacol. 2023 Jan 9;13:1119073. doi: 10.3389/fphar.2022.1119073. eCollection 2022. Front Pharmacol. 2023. PMID: 36699076 Free PMC article. No abstract available.
52 results